Literature DB >> 32691060

Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma.

Karolina Woroniecka1, Peter E Fecci1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32691060      PMCID： PMC7523436          DOI： 10.1093/neuonc/noaa170

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  7 in total

1.  Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

Authors:  John H Sampson; Amy B Heimberger; Gary E Archer; Kenneth D Aldape; Allan H Friedman; Henry S Friedman; Mark R Gilbert; James E Herndon; Roger E McLendon; Duane A Mitchell; David A Reardon; Raymond Sawaya; Robert J Schmittling; Weiming Shi; James J Vredenburgh; Darell D Bigner
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

2.  Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine.

Authors:  Connor J Liu; Maximilian Schaettler; Dylan T Blaha; Jay A Bowman-Kirigin; Dale K Kobayashi; Alexandra J Livingstone; Diane Bender; Christopher A Miller; David M Kranz; Tanner M Johanns; Gavin P Dunn
Journal:  Neuro Oncol       Date:  2020-09-29       Impact factor: 12.300

Review 3.  T-cell Dysfunction in Glioblastoma: Applying a New Framework.

Authors:  Karolina I Woroniecka; Kristen E Rhodin; Pakawat Chongsathidkiet; Kristin A Keith; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2018-03-28       Impact factor: 12.531

4.  Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach.

Authors:  Tanner M Johanns; Jeffrey P Ward; Christopher A Miller; Courtney Wilson; Dale K Kobayashi; Diane Bender; Yujie Fu; Anton Alexandrov; Elaine R Mardis; Maxim N Artyomov; Robert D Schreiber; Gavin P Dunn
Journal:  Cancer Immunol Res       Date:  2016-10-31       Impact factor: 11.151

5.  T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma.

Authors:  Karolina Woroniecka; Pakawat Chongsathidkiet; Kristen Rhodin; Hanna Kemeny; Cosette Dechant; S Harrison Farber; Aladine A Elsamadicy; Xiuyu Cui; Shohei Koyama; Christina Jackson; Landon J Hansen; Tanner M Johanns; Luis Sanchez-Perez; Vidyalakshmi Chandramohan; Yen-Rei Andrea Yu; Darell D Bigner; Amber Giles; Patrick Healy; Glenn Dranoff; Kent J Weinhold; Gavin P Dunn; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2018-02-07       Impact factor: 12.531

Review 6.  Recurrent glioma clinical trial, CheckMate-143: the game is not over yet.

Authors:  Anna C Filley; Mario Henriquez; Mahua Dey
Journal:  Oncotarget       Date:  2017-10-06

7.  Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.

Authors:  Pakawat Chongsathidkiet; Christina Jackson; Shohei Koyama; Franziska Loebel; Xiuyu Cui; S Harrison Farber; Karolina Woroniecka; Aladine A Elsamadicy; Cosette A Dechant; Hanna R Kemeny; Luis Sanchez-Perez; Tooba A Cheema; Nicholas C Souders; James E Herndon; Jean-Valery Coumans; Jeffrey I Everitt; Brian V Nahed; John H Sampson; Michael D Gunn; Robert L Martuza; Glenn Dranoff; William T Curry; Peter E Fecci
Journal:  Nat Med       Date:  2018-08-13       Impact factor: 53.440
  7 in total
  4 in total

Review 1.  The multifaceted mechanisms of malignant glioblastoma progression and clinical implications.

Authors:  Rui Sun; Albert H Kim
Journal:  Cancer Metastasis Rev       Date:  2022-08-03       Impact factor: 9.237

Review 2.  Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic Combinations.

Authors:  Marcin Niedbała; Katarzyna Malarz; Gitanjali Sharma; Gabriela Kramer-Marek; Wojciech Kaspera
Journal:  Onco Targets Ther       Date:  2022-04-28       Impact factor: 4.345

3.  The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic review.

Authors:  Kyra X Swildens; Peter A E Sillevis Smitt; Martin J van den Bent; Pim J French; Marjolein Geurts
Journal:  Neurooncol Adv       Date:  2022-06-07

4.  Durable Response to Immunotherapy With Antiangiogenic Drug in Large-Cell Lung Carcinoma With Multiple Fulminant Postoperative Metastases: A Case Report.

Authors:  Zhilin Luo; Hong Zhang; Yajie Xiao; Rui Wang; Liping Zhang; Chenglu Huang; Yu Cao; Chao Sun; Yongtian Zhao; Hanqing Lin; Dongfang Wu; Tianhu Wang
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.